Roche and Labroots are pleased to announce the first-ever global DISCOVERY user symposium. This two-day event will take place November 12-13, 2020 and will focus on advancements in tissue research. This event is a peer to peer meeting, allowing you to hear from fellow researchers about their work with the DISCOVERY product portfolio.
Our virtual symposium allows you to participate in a global setting with no travel or cost to you. This virtual symposium also offers increased reach for the global DISCOVERY community with a high degree of interaction through live-streaming video and chat sessions.
Register Now to access the following beginning on November 12th:
DISCOVERY products are for research use only. Not for use in diagnostic procedures.
Nelson Alexander received his Ph.D. in Cancer Biology from the University of Arizona, followed by a post-doctoral fellowship at Vanderbilt University. Looking to have a more direct impact on patient care, he joined Roche Tissue Diagnostics (RTD) in 2007 where he has held multiple roles in R&D, as well as Research & Early Development. During his time at RTD Nelson became very interested in the interface between tumor heterogeneity and sampling bias. Nelson currently lead a research team within Roche Sequencing Solutions that is pioneering a new sampling process that enables the evaluation and quantification of tumor diversity at the genomic, transcriptomic, and cellular levels from entire solid tumors.
Srabani Bhaumik is a Staff Scientist in the Strategic Applications and Innovation Lab at Roche Tissue Diagnostics. Her R&D experiences includes molecular imaging, molecular pathology, small animal imaging, MRI contrast media imaging, reporter gene imaging, regenerative medicine and in-vitro assay development in oncology. Her current work is focused on fluorescent multiplexing (mIF) assay development on Roche automated IHC/ISH instruments, image acquisition and image analysis on multiple platforms. She was the technical lead for the development and launch of the fluorescent RUO 5-Plex assay on Roche Discovery platform. She has successfully developed complex fluorescent multiplex assays on various oncology samples including 3D cell spheroids and cytology. Prior to Roche, she worked at General Electric Global Research, where she focused on the MultiOmyx platform to explore immune oncology biomarker.
Sara Eglitis is a former scientist at NovoVita Histopath Laboratory, a CRO in Boston, MA specializing in a wide ranging of histopathology services including immunohistochemistry and digital image analysis. She is now Laboratory Director at StageBio.
Charalambos Solomides began his career in medicine at the Rheinishe Friedrich-Wilhelms University of Bonn, Germany, where he attended Medical School. Following graduation in 1988 with a Degree in Medicine he successfully completed his medical doctorate thesis in 1991, and graduated from the same university with a Doctorate of Medicine (Dr. Med.). Following 2 years in clinical research at Albany Medical College in NY, USA (1991-1993), he enrolled in the Residency Pathology Program of Temple University Hospital (TUH) in Philadelphia (1993). He completed his Residency in Pathology in 1998 and a Fellowship in Cytopathology 1999 at Thomas Jefferson University. He joined the faculty at TUH, Department of Pathology in 1999 as Assistant and later as Associate Professor of Pathology and Director of Cytopathology (2004). In 2009 he joined the Department of Pathology at Thomas Jefferson University Hospital in Philadelphia where is currently The Warren R. Lang Professor of Pathology, Anatomy and Cell Biology and Director of Cytopathology and the Immunohistochemistry Lab. His special interest is in Cytopathology and Lung Pathology. Charalambos has published over 70 publications in peer reviewed journals and 2 book chapters.
Faruk Erdem Kombak is a research associate in Memorial Sloan Kettering Cancer Center, New York. He has been working in Precision Pathology Biobanking Center of this institution since September 2019. He was born in Turkey, in 1986 and completed his medical degree in Istanbul University, Turkey, in 2010. He finished his anatomical pathology residency in Marmara University, Turkey, in 2016. He worked as attending pathologist in Turkey for 3 years. In his current position; he performs histological and immunohistochemical assessment for clinical trials/scientific projects as well as multiplex immunohistochemistry and tissue microarray construction.
Vivian Barry is a Senior Scientist in the Pathobiology group at Gilead Sciences. She began her career in molecular biology and immunology research areas at DNAX and Genentech. She eventually ventured into histopathology research and became the manager of the immunohistochemistry team at Arresto Biosciences in 2008. Vivian joined Gilead in 2011, with the acquisition of Arresto, and has been managing the IHC/Pathology group at Gilead since that time. Over the years, she has focused on building the histopathology lab and has introduced various machinery and techniques to enhance the delivery of high quality IHC and CISH data. Her team focuses on target validation in both human tissues and animal models, assists in determining mechanism of action of therapeutics and small molecules, and is involved in IND-enabling studies. She collaborates with investigators across Gilead’s departments; these projects include virology, immunology, oncology, and fibrotic diseases. Vivian received her Bachelor of Science and Master of Science degrees at the University of San Francisco, and has recently received her MBA from the Golden Gate University, San Francisco.
Mr. Hellewell has been with Roche Tissue Diagnostics (RTD) for 8 years where he has held several positions within the company. He began his career with RTD UK where he held sales and applications positions. In 2016 he relocated to Tucson, AZ to take up a global role with customer support for RTD. In 2017 he joined the DISCOVERY International Business team as Global Reagent and Training Lead, where he manages their reagent portfolio and global DISCOVERY training activities for customers and RTD personnel.
Bring your toughest challenge or simplest questions to our DISCOVERY portfolio experts. The team will be available by Live Chat during the conference hours. Our technical support team will be ready to assist with questions on DISCOVERY installation, protocol development and even offer multiplexing suggestions for your most challenging projects. Just look for the Ask the Expert "Kiosk" during the Symposium.
The speakers below have been approved for Continuing Education Credits. To redeem your credits, locate the presentation you watched and click on the CE buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here
Join a Zoom "Virtual Roundtable" with the Symposium speakers on both Nov 12 at 14.30 (EDT) and Nov 13 at 18.30 PDT. Speakers will field questions from symposium attendees in a moderated session. A great chance to "speak live" with colleagues on their groundbreaking research.
Come learn the latest developments in Roche's Research portfolio. There will be "Exhibit booths" for
|Operating System||Internet Explorer||Firefox||Chrome||Safari|
|Windows 7||IE8+||FF10+||Chrome15+||Windows 8||IE10||FF10+||Chrome15+|
|Mac OS X||FF10+||Chrome15+||Safari5.1+|
- For viewing Webinars:
- For viewing Virtual Events